Skip to main content

Find Clinical Trials

Home
Conditions
Hepatocellular Carcinoma

Clinical trial condition

Hepatocellular Carcinoma

Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

1,013 public trials 264 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma trial results

Not Yet Recruiting

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

NCT07252661

Conditions: Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Diseases, +44 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Trial of TB511 in Advanced Solid Tumors

NCT06400160

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +27 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors

NCT07224568

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +22 more
Locations: Fred Hutch Cancer Center Seattle, Washington, United States

View Trial Details

Not Yet Recruiting

GKL-006 Combined With TACE in Treatment of Unresectable Hepatocellular Carcinoma

NCT07209813

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study

NCT07180459

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: People's Hospital of Kaiyang County Guiyang, Guizhou, China

The Second Affiliated Hospital of Hainan Medical Universsity Haikou, Hainan, China

Huai He Hospital of Henan University Kaifeng, Henan, China

Luo He Central Hospital Luohe, Henan, China

View Trial Details

Not Yet Recruiting

Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma

NCT07157306

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma

NCT07131501

Conditions: Adenocarcinoma, CTLA-4, Carcinoma, +14 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy

NCT07118735

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: No. 138, Shengli Rd., North Dist Tainan, Taiwan

View Trial Details

Not Yet Recruiting

Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment

NCT07078305

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study

NCT07064668

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tongji Medical college of HUST Wuhan, Hubei, China

View Trial Details